"Pseudomonas aeruginosa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
| Descriptor ID |
D011550
|
| MeSH Number(s) |
B03.440.400.425.625.625.100 B03.660.250.580.590.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pseudomonas aeruginosa".
Below are MeSH descriptors whose meaning is more specific than "Pseudomonas aeruginosa".
This graph shows the total number of publications written about "Pseudomonas aeruginosa" by people in this website by year, and whether "Pseudomonas aeruginosa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 0 | 3 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 3 | 4 |
| 2003 | 1 | 3 | 4 |
| 2004 | 2 | 1 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 3 | 3 | 6 |
| 2009 | 2 | 0 | 2 |
| 2010 | 3 | 2 | 5 |
| 2011 | 5 | 2 | 7 |
| 2012 | 3 | 2 | 5 |
| 2013 | 2 | 2 | 4 |
| 2014 | 0 | 2 | 2 |
| 2015 | 4 | 0 | 4 |
| 2016 | 6 | 4 | 10 |
| 2017 | 2 | 2 | 4 |
| 2018 | 3 | 1 | 4 |
| 2019 | 3 | 4 | 7 |
| 2020 | 5 | 1 | 6 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pseudomonas aeruginosa" by people in Profiles.
-
Antipseudomonal treatment decisions during CF exacerbation management. J Cyst Fibros. 2022 09; 21(5):753-758.
-
Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections. Nat Commun. 2022 03 09; 13(1):1231.
-
Poly (acetyl, arginyl) glucosamine disrupts Pseudomonas aeruginosa biofilms and enhances bacterial clearance in a rat lung infection model. Microbiology (Reading). 2022 01; 168(1).
-
Alcaligenes faecalis metallo-?-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates. Clin Microbiol Infect. 2022 Jun; 28(6):880.e1-880.e8.
-
Predicting drug targets by homology modelling of Pseudomonas aeruginosa proteins of unknown function. PLoS One. 2021; 16(10):e0258385.
-
Use of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literature. Int J Antimicrob Agents. 2020 Nov; 56(5):106158.
-
Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate. J Vis Exp. 2020 02 22; (156).
-
Nanosilver Mitigates Biofilm Formation via FapC Amyloidosis Inhibition. Small. 2020 05; 16(21):e1906674.
-
Facial Amphiphilicity-Induced Polymer Nanostructures for Antimicrobial Applications. ACS Appl Mater Interfaces. 2020 May 13; 12(19):21221-21230.
-
Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection. J Vis Exp. 2020 01 08; (155).